A compound, pharmaceutical composition, processes for treating or preventing cancer, a disease in which angiogenesis is implicated, retinal vascularization, diabetic retinopathy, age-related macular degeneration, inflammatory diseases, tyrosine-dependent disease or conditions. kinase, bone-associated pathologies, and processes for producing a pharmaceutical composition, and for reducing or preventing tissue damage following a cerebral ischemic event

摘要

"COMPOSITION, PHARMACEUTICAL COMPOSITION, PROCESSES OF TREATMENT OR PREVENTION OF CANCER, OF A DISEASE IN WHICH ANGIOGENESIS IS IMPLIED, RETINAL VASCULARIZATION, DIABETIC DIAGNOSIS, INFLUATION OF THE DISEASE RELATED TO THE DISEASE TYROSINE KINASE, OF BONE-ASSOCIATED PATHOLOGIES, AND PROCESSES TO PRODUCE PHARMACEUTICAL COMPOSITION, AND TO REDUCE OR PREVENT TISSUE DAMAGE AFTER CEREMIC ISCHEMICAL EVENT ". The present invention relates to compounds that inhibit, regulate and / or modulate tyrosine kinase signal transduction, compositions containing these compounds, and methods for using them to treat tyrosine kinase dependent diseases and conditions, such as angiogenesis, cancer, tumor growth, arteriosclerosis, age-related macular degeneration, diabetic retinopathy, inflammatory diseases, and others in mammals.